Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (140)
  2. Journal Article (96)
  3. Book Section (8)
  4. Review (8)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (256)
  2. Department of Medicine (256)
  3. Solid Tumor Oncology Division (256)
  4. Survivorship Research (256)
  5. Epidemiology and Biostatistics (102)
  6. Biostatistics Service (87)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (9)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (79)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (17)
  6. Future Medicine (5)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/Ib study of enzalutamide alone and in combination with endocrine therapies in women with advanced breast cancer
    Journal Article

    Schwartzberg, L. S.; Yardley, D. A.; Elias, A. D.; Patel, M.; LoRusso, P.; Burris, H. A.; Gucalp, A.; Peterson, A. C.; Blaney, M. E.; Steinberg, J. L.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Androgen receptor-positive, triple-negative breast cancer
    Journal Article

    Gucalp, A.; Traina, T. A.
    Cancer (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer
    Meeting Abstract

    Dent, R.; Schmid, P.; Cortes, J.; Kim, S. B.; Andre, F.; Abramson, V.; Cardoso, F.; Colleoni, M.; Morris, P.; Steinberg, J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Pilot trial of an implantable microdevice for in vivo drug sensitivity testing in patients with early stage, triple negative breast cancer receiving neoadjuvant therapy
    Meeting Abstract

    Traina, T. A.; Plitas, G.; Reis-Filho, J. S.; Morris, E. A.; Hughes, M.; Sung, J. S.; Patil, S.; Piscuoglio, S.; Park, S.; Greenberg, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Corben, A.; Moynahan, M. E.; Patil, S.; Boyle, L. A.; Hudis, C. A.; Traina, T. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR plus triple negative (TNBC) or estrogen receptor (ER) plus breast cancer (BC)
    Meeting Abstract

    Bardia, A.; Dacosta, N. A.; Gabrail, N. Y.; Lemon, S.; Danso, M. A.; Ali, H. Y.; Fleming, R. A.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)
    Meeting Abstract

    Gucalp, A.; Corben, A.; Patil, S.; Boyle, L. A.; Hudis, C.; Traina, T. A.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save